Determination of Elemental Impurities in Pharmaceuticals

This case study explores the use of PlasmaQuant 9100 Elite high-resolution ICP-OES technology for determining trace elemental impurities in pharmaceutical products. It discusses compliance with USP chapters <232> and <233>, and ICH Q3D guidelines, highlighting the system's sensitivity, robustness, and ability to analyze diverse sample types efficiently. The document emphasizes the importance of accurate quantification for pharmaceutical safety and regulatory compliance.